Drug Profile
Verapamil sustained release - Beijing CoSci Med Tech
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Beijing CoSci Med-Tech
- Class Antihypertensives; Antimigraines; Class IV antiarrhythmics; Ischaemic heart disorder therapies; Nitriles; Phenethylamines; Small molecules; Vasodilators
- Mechanism of Action Calcium channel antagonists; Cytochrome P 450 enzyme system inhibitors; P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Essential hypertension
Most Recent Events
- 27 Jul 2016 Chemical structure information added
- 22 Jul 2016 Investigation in Essential hypertension in China (PO)